Ahmed Hamdy MD - 07 Mar 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VINC	Stock Option (right to buy)	Award	$0	+146,746		$0.000000	146,746	07 Mar 2024	Common Stock	146,746	$7.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.